Ophthalmology Market: Opportunity for Growth Remains

Market Insight: By:  Echoe Bouta, PhD, Scott Terchiak, and Oded Ben-Joseph, PhD, MBA

 


The ophthalmology market values innovative approaches, demonstrated by premiums paid for acquisition of  first-in-class therapies and public market support of ophthalmology gene therapy companies.

Total economic burden of vision loss and eye disorders surpasses $130 billion in the U.S., a figure expected to rise due to the aging population.  We examined recent ophthalmology market dynamics between 2015 and 2018, including industry-sponsored clinical trials, financing events, mergers and acquisition transactions and initial public offerings. These dynamics are utilized to assess the overall activity of the sector and interest by venture capitalists, strategic players and the public market.

 

View Full Article

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • New York

    555 Fifth Ave.
    19th Floor
    New York, NY 10017
    (212) 350-8213

  • Boston

    99 High St.
    Suite 2900
    Boston, MA 02110
    (617) 431-4886

  • Washington DC

    11921 Freedom Dr.
    Suite 730
    Reston, VA 20190
    (617) 431-4886